Cholestatic Liver Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cholestatic liver disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cholestatic Liver Disease Today - Breaking & Trending Today

Mark Sundrud, PhD: Bile Acid and T Cell Interplay in Cholestatic Diseases

We sat down with Mark Sundrud, PhD, to discuss bile acids and T cells in cholestatic liver disease and the future of research regarding the interplay between intestinal and liver functions. ....

United States , Mark Sundrud , Geisel School Of Medicine At Dartmouth College , Geisel School , Dartmouth College , Gut Liver Axis , Therapeutic Target , Cholestatic Liver , Liver Meeting , American Association , Liver Diseases , T Cell , Bile Acid , Cholestatic Liver Disease ,

Ipsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBC

French pharmaceutical company Ipsen SA (IPSEY) and late-stage biopharmaceutical company GENFIT SA (GNFT) announced Friday positive topline data from the pivotal ELATIVE Phase III trial of elafibranor in patients with primary biliary cholangitis or PBC, a rare cholestatic liver disease. ....

More Such Health News , Drug Administration , European Medicines Agency , Breakthrough Therapy , Primary Biliary Cholangitis , Lative Phase Iii Trial , Cholestatic Liver Disease ,

Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline

/PRNewswire/ Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat rare serious. ....

San Diego , United States , United Kingdom , Northern Ireland , Ignacio Guerrero Ros , Shire Pharmaceuticals , Amplyx Pharmaceuticals , Arena Pharmaceuticals , Sorriso Pharmaceuticals , Pfizer Inc , Cypress Bioscience Inc , Alliance Department , Biogen Idec , Cambridge University Department Of Pathology , Queen University Of Belfast , Lumena Pharmaceuticals , Neuroscience At Genentech Inc , Chief Executive Officer , Chief Operating Officer , Vice President , Cholestatic Liver Disease , Principal Medical Director , Medical Director , Genentech Inc , Senior Medical Director , Cambridge University Department ,

Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline

/PRNewswire/ Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat rare serious. ....

San Diego , United States , United Kingdom , Northern Ireland , Ignacio Guerrero Ros , Shire Pharmaceuticals , Amplyx Pharmaceuticals , Arena Pharmaceuticals , Sorriso Pharmaceuticals , Pfizer Inc , Cypress Bioscience Inc , Alliance Department , Biogen Idec , Cambridge University Department Of Pathology , Queen University Of Belfast , Lumena Pharmaceuticals , Neuroscience At Genentech Inc , Chief Executive Officer , Chief Operating Officer , Vice President , Cholestatic Liver Disease , Principal Medical Director , Medical Director , Genentech Inc , Senior Medical Director , Cambridge University Department ,